Coated microneedle-based cutaneous immunotherapy prevents Der p 1–induced airway allergy in mice

Der p1-coated microneedles after just three minutes of application led to efficient allergen delivery into skin and prevented development of airway allergy in a mouse. Allergen-coated microneedles may have potential for minimally-invasive allergen vaccination and immunotherapy.